Catalyst Wire Dossier Catalyst Wire Dossier

Becaplermin (Regranex)

becaplermin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Becaplermin (Regranex), covering 2016-07-19 to 2016-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

See pricing